Navigation Links
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
Date:4/24/2008

- Findings Published in the British Journal of Hematology -

FREMONT, Calif., April 24 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML) today reported findings from an Ohio State University (OSU) clinical study that indicated that a surface-enhanced laser desorption/ionization time of flight (SELDI-TOF)-based thrombotic thrombocytopenic purpura (TTP) diagnostic test could be used to help estimate the risk of TTP relapses during clinical remission. OSU currently offers the TTP test as a laboratory developed test, based on an exclusive licensing agreement with Vermillion, and for which Vermillion sells OSU supplies and laboratory reagents.

The data -- published recently in the online edition of the British Journal of Haematology -- indicate that use of the test may provide a novel screening strategy to identify patients who may benefit from prophylactic treatment to help prevent relapse of this serious blood disorder. TTP is caused by a deficient activity of the enzyme ADAMTS13, which leads to platelet clumping, red blood cell destruction, and, in serious cases, to neurological abnormalities and renal failure.

"TTP is a life-threatening disease that affects thousands of people each year. The disease is characterized by frequent recurrences, with approximately half of all patients experiencing relapses," said Haifeng M. Wu, M.D., lead investigator of the study and Assistant Professor of Pathology and Medicine and Director of the Clinical Coagulation Laboratory at OSU Medical Center. "The SELDI-TOF technology was instrumental in improving sensitivity for extremely low levels of ADAMTS13, which may be used to help identify patients who could be candidates for prophylactic treatment based upon their increased ri
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
7. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
8. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
9. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015 Semler Scientific, Inc. (Nasdaq: ... that develops, manufactures and markets products that assist healthcare ... reported financial results for the first quarter ended March ... of 2015, Semler reported continued progress with year over ... revenue growth of 14%," said Doug Murphy-Chutorian , ...
(Date:5/1/2015)... -- Cambrex Corporation (NYSE: CBM ) reports results for ... Highlights , Sales increased 18% compared to the ... impact, driven by Innovator products and Controlled Substances. , ... first quarter of 2014. , GAAP Diluted EPS from ... last year and Adjusted Diluted EPS was $0.29 compared to ...
(Date:4/30/2015)... 2015 Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the fourth quarter and ... quarter and fiscal 2015 overview: , Revenues from ... up 33% over last year,s comparable quarter, and $202.6 ... Diluted EPS of $0.50 for the fourth quarter, up ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22
... Fla., Nov. 7 Results from the,latest ... were presented,today here at the American Heart ... relationship between decreased microvascular,function and cardiovascular risk., ... Itamar Medical,s ENDO-Pat device was the diagnostic ...
... on Aspirin Therapy Can Safely Take Aleve for ... Pain Without Compromising Cardiovascular Benefits, BOSTON, Nov. 7 ... of the American College of Rheumatology (ACR) showed that ... was,added to an aspirin therapy regimen, there was no ...
Cached Medicine Technology:New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease 2Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium 2Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium 3Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium 4
(Date:5/4/2015)... Today, Cireson reveals the following key announcements:, ... to strengthen core service & asset management solutions , ... Microsoft System Center and Cireson via Microsoft Azure in ... Company transitioning from a direct sales presence to 100% ... expanding new solutions for password reset management, gamification, self-service ...
(Date:5/3/2015)... Michigan (PRWEB) May 03, 2015 Barbara Crone has ... to enhance the well being of the men, women and families ... hospital, followed by providing care for families in the home. ... Adult Nurse Practitioner began wondering if I could complete their care ... my own children with my mentor Nurse Midwife, I knew it ...
(Date:5/3/2015)... San Francisco, CA (PRWEB) May 03, 2015 ... International (CFHI), announced it will be awarding the ... Scholars, Jennifer Knight and Selemawit Ghebrendrias, are the deserving ... and champion for global service, Harris Llewellyn Wofford. The ... global service and passion for global health. , ...
(Date:5/3/2015)... BolehVPN ” was featured on NewsWatch as part of its ... products available to consumers. Scott Steinberg, a technology expert and ... viewers how to protect their private information. , A lot ... even more so online. It helps everyone stay connected with ... In terms of work, the internet makes things more efficient. ...
(Date:5/3/2015)... 03, 2015 SpineFrontier, a Less Exposure ... FDA to produce and market their new sacroiliac joint ... used in outpatient settings and is compatible with both ... approach has been extensively researched and refined by SpineFrontier, ... use this approach in conjunction with a sacroiliac joint ...
Breaking Medicine News(10 mins):Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2
... LITTLE FALLS, N.J., Aug. 3 CANTEL MEDICAL CORP. ... has continued the expansion of its water purification and filtration segment ... LLC. G.E.M. designs, builds, installs and services high quality water ... business had pre-acquisition revenues of approximately $3.5 million. This cash ...
... the risk of trouble, expert says, , MONDAY, Aug. 3 ... physical education programs to battle the childhood obesity epidemic, the ... dramatically, Ohio State University researchers report. , In fact, ... to physical education (PE) increased 150 percent -- from 24,000 ...
... BERKELEY HEIGHTS, N.J., Aug. 3 Authentidate ... worldwide provider of secure Health Information Exchange and ... of America, Inc., a leading provider of home ... South Carolina, will implement Authentidate,s Inscrybe(TM) Healthcare web-based ...
... , Expert recommends parents and schools ... ANN ARBOR, Mich., Aug. 3 As a bright, young ... had everything going for her. , , But when ... on hand, Laura landed on her head fracturing her neck and damaging ...
... , ARDEE, Ireland, Aug. 3 Warner Chilcott Limited ... two Paragraph IV Certification Notices from Lupin Ltd. ("Lupin"). The ... Abbreviated New Drug Applications (ANDAs) by Lupin for generic versions of ... , , LOESTRIN 24 FE, which was launched ...
... , , LEAGUE CITY, Texas, Aug. ... been dedicated to the insurance needs of seniors, with an unyielding ... Agent. This has never been more evident than in the introduction ... 2009. , , With the advent of the ...
Cached Medicine News:Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 2Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 3Health News:Gym Class Injuries Up 150 Percent 2Health News:Gym Class Injuries Up 150 Percent 3Health News:Medical Services of America Selects Authentidate's Inscrybe Healthcare to Standardize Healthcare Order Process Management 2Health News:Medical Services of America Selects Authentidate's Inscrybe Healthcare to Standardize Healthcare Order Process Management 3Health News:Medical Services of America Selects Authentidate's Inscrybe Healthcare to Standardize Healthcare Order Process Management 4Health News:Cheerleading is Leading Cause of Catastrophic Injury in Young Women 2Health News:Cheerleading is Leading Cause of Catastrophic Injury in Young Women 3Health News:Warner Chilcott Announces Receipt of Paragraph IV Certification Notices 2Health News:Warner Chilcott Announces Receipt of Paragraph IV Certification Notices 3Health News:SLAICO Takes the Medicare Supplement Application Online - Eliminating All Paperwork Offline. 2